Publicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (25)

2024

  1. Kimioterapiaren ondorengo anemiaren eta sukar-neutropeniaren maneiua

    Osagaiz: osasun-zientzien aldizkaria, Vol. 8, Núm. 1, pp. 101-106

  2. Ospitaleko farmazialariaren eta medikuaren arteko elkarlana GIBa duten pazienteen tratamenduen eraginkortasuna eta segurtasuna bermatzeko

    Osagaiz: osasun-zientzien aldizkaria, Vol. 8, Núm. 1, pp. 51-58

2023

  1. Effect of the combination of diuretics, renin–angiotensin–aldosterone system inhibitors, and non-steroidal anti-inflammatory drugs or metamizole (triple whammy) on hospitalisation due to acute kidney injury: A nested case–control study

    Pharmacoepidemiology and Drug Safety, Vol. 32, Núm. 8, pp. 898-909

  2. Pilot study of a European oncology regimen reference library and matching algorithm

    European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 227-231

  3. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

    Scientific reports, Vol. 13, Núm. 1, pp. 12159

2022

  1. Betalaktamikoekiko alergia: osasun-langileon erantzukizuna

    Osagaiz: osasun-zientzien aldizkaria, Vol. 6, Núm. 1, pp. 145-150

  2. Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component

    Gaceta Sanitaria, Vol. 36, Núm. 3, pp. 246-252

  3. Outpatient pharmaceutical care satisfaction survey through Telepharmacy during COVID-19 pandemic in Spain

    Farmacia Hospitalaria, Vol. 46, pp. 69-85

2021

  1. Antineoplasikoen albo-ondorioak: zein dira eta nola maneiatzen dira?

    Osagaiz: osasun-zientzien aldizkaria, Vol. 5, Núm. 2, pp. 119-128

  2. Evaluation of the collaboration between Primary and Hospital Care in order to improve inappropriate prescription

    Journal of Healthcare Quality Research, Vol. 36, Núm. 2, pp. 91-97

  3. Identifying options for oncology therapy regimen codification to improve standardization—combined results of an expert panel and a review

    Journal of Clinical Pharmacy and Therapeutics, Vol. 46, Núm. 5, pp. 1238-1244

  4. Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models

    PLoS ONE, Vol. 16, Núm. 2 February

  5. Outpatients’ Opinion And Experience Regarding Telepharmacy During The COVID-19 Pandemic: The Enopex Project

    Journal of Multidisciplinary Healthcare, Vol. 14, pp. 3621-3632

  6. Survey of diagnostic resources for STI in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 8, pp. 390-394

  7. Zer egin paziente baten behar klinikoak asetzeko sendagaiak osasun-sistema publikoko farmazia-prestazioaren barruan ez badaude?

    Osagaiz: osasun-zientzien aldizkaria, Vol. 5, Núm. 1, pp. 137-140

2020

  1. Farmazia-prestazioa, zer sendagai ordainduko dira eta zer preziotan?

    Osagaiz: osasun-zientzien aldizkaria, Vol. 4, Núm. 2, pp. 95-99

  2. Immunotherapy with CAR-T cells in paediatric haematology-oncology

    Anales de Pediatria, Vol. 93, Núm. 1, pp. 59.e1-59.e10

  3. Online farmazia-arreta onkologiaren arloan: eredu pilotu berriak garatzen

    Osagaiz: osasun-zientzien aldizkaria, Vol. 4, Núm. 1, pp. 29-38

2019

  1. Antibiotikoak: guztion altxorra, guztion ardura

    Osagaiz: osasun-zientzien aldizkaria, Vol. 3, Núm. 1, pp. 111-115

  2. Dietary inflammatory index, dietary non-enzymatic antioxidant capacity, and colorectal and breast cancer risk (MCC-Spain study)

    Nutrients, Vol. 11, Núm. 6